Rigetti Computing (RGTI) — Company Research

Last Updated: 27 May 2026

Rigetti Computing Inc. (NASDAQ: RGTI) is a pure-play quantum computing company building modular gate-based quantum processors using superconducting qubits. Founded in 2013 by physicist Chad Rigetti and headquartered in Berkeley, California, it competes directly with IBM, Google and IonQ in the race to build commercially useful gate-model quantum hardware. In May 2026 the company brought its 108-qubit Cepheus-1-108Q system into general availability across its own Quantum Cloud Services platform and on Amazon Braket, Microsoft Azure Quantum and qBraid — a meaningful milestone for its modular chiplet-based architecture. The balance sheet is unusually strong for a loss-making deep-tech company: $569m of cash and investments and zero corporate debt as of 31 March 2026.

1. Company Snapshot

Rigetti went public in March 2022 via a SPAC merger with Supernova Partners Acquisition Company II. Dr. Subodh Kulkarni, the current CEO, joined in December 2022 from CyberOptics where he led a successful sale to Nordson Corporation. His semiconductor background is central to the company’s “quantum-as-a-chip” thesis — treating superconducting qubits as a fabrication and packaging problem rather than a pure physics problem.

2. Bull & Bear

Bull Case

• Largest modular system on the market: The 108-qubit Cepheus-1-108Q is the industry’s largest modular gate-based quantum computer in general availability and validates Rigetti’s chiplet architecture in a production environment.
• Cash-rich balance sheet: $569m of cash and investments and zero corporate debt provides a runway measured in years even at current burn rates, dramatically reducing near-term dilution risk.
• Government and sovereign demand: $8.4m purchase order from India’s C-DAC, plus plans to invest up to $100m in the UK toward a >1,000-qubit system, demonstrates Rigetti’s growing role in sovereign quantum strategy.
• Triple-digit revenue growth in Q1 2026: Q1 2026 revenue grew 193% year-on-year to $4.4m, suggesting the FY2025 revenue dip may have been a transition issue rather than a structural one.
• Semiconductor-trained leadership: CEO Kulkarni’s thirty-plus years of public-company semiconductor leadership give Rigetti a more disciplined operational template than peer pure-plays led by founder-physicists.

Bear Case

• Extreme valuation against current revenue: An ~$8.8bn market cap on $7.1m of FY2025 revenue equates to a price-to-sales ratio well above 1,000x — pricing in years of perfect execution against well-resourced incumbents.
• Revenue declined three years in a row: FY2025 revenue of $7.1m was 34% lower than FY2024 and 41% lower than FY2023; even with Q1 2026’s rebound, the trajectory has been negative until very recently.
• Heavy-hitter competition: IBM (with $1bn cumulative quantum bookings and a $1bn federal grant), Google’s Willow chip programme, and IonQ’s $130m+ revenue scale are all formidable; Rigetti is competing for the same gate-model market as much larger rivals.
• Cash burn ahead of revenue: FY2025 free cash flow of approximately −$77m on $7.1m of revenue gives a striking burn-to-revenue ratio; the cash position buys time but does not solve the fundamental commercial-traction question.
• GAAP Q1 net income flattered by non-cash gains: The reported Q1 2026 GAAP net income of $33.1m is misleading; the non-GAAP net loss of $14.7m and operating loss of $26.0m better reflect the underlying economics.

3. Business Segments

Rigetti does not break out reportable operating segments in its financial filings, but its revenue can be grouped into three product lines.

Geographically, the U.S. is the largest revenue source today, with growing contribution from the UK, India and Australia. The international mix is expected to broaden meaningfully through 2026 and 2027 as the UK and India deployments come online.

4. Business Model & Moat

How it makes money. Three revenue channels: government and corporate research contracts (typically multi-year, milestone-billed), outright system sales (multi-million-dollar tickets, recognised on delivery and acceptance), and cloud subscription access to Rigetti hardware via its own QCS platform and the major hyperscalers. The mix is currently weighted to research contracts but expected to shift toward system sales and recurring cloud revenue as the Cepheus-1-108Q ramps.

The moat. Rigetti’s competitive position rests on three pillars. First, its modular chiplet architecture — building larger systems from interconnected smaller chiplets — is a credible scaling pathway in superconducting quantum and is a genuine engineering differentiator versus monolithic designs. Second, it operates one of the very few in-house quantum chip fabrication facilities globally (Fab-1 in Fremont, California), giving it tight iteration cycles. Third, it has built relationships with sovereign quantum programmes in the U.S., UK and India that act as long-term anchor customers.

Where the moat is thin. The largest competitor — IBM — has a multi-decade head start and over $1bn of cumulative quantum bookings; Google’s Willow chip programme has demonstrated leading error-correction milestones; and IonQ’s trapped-ion approach has so far delivered higher gate fidelities. Rigetti must execute against all three simultaneously.

5. Financial Health

Rigetti is a small-revenue, cash-consuming company in the very early stages of gate-model quantum commercialisation. The headline pattern is multi-year revenue volatility, large GAAP losses (compounded by non-cash warrant fair-value movements), and a heavily over-funded balance sheet from multiple equity raises during 2024 and 2025.

Quarterly revenue is dominated by the timing of system deliveries and research-contract milestones; the FY2025 fourth-quarter print of $1.87m missed consensus expectations by approximately 22%, while Q1 2026 then rebounded sharply to $4.4m on the back of the Cepheus general-availability launch.

Cash, cash equivalents and available-for-sale investments stood at $569.0m at 31 March 2026, supported by successive equity issuances in 2024 and 2025. The company has zero corporate term debt — balance-sheet liabilities are dominated by warrant liabilities, lease obligations and accrued expenses rather than borrowings. Accumulated deficit was approximately $771m at year-end 2025.

6. Valuation

Raw metrics, May 2026. Not opinions on whether the stock is cheap or expensive.

As with all quoted pure-play quantum names, conventional earnings and cash-flow multiples are non-meaningful at this stage; the price-to-sales ratio is extreme and discounts a multi-year ramp to commercial scale. Investors are effectively buying optionality on a future market that does not yet exist.

7. Growth Drivers

Cepheus-1-108Q general availability. Bringing a 108-qubit modular system into general availability across QCS, AWS Braket, Azure Quantum and qBraid materially widens the funnel of paying users; the Q1 2026 revenue rebound is the first signal that this is translating into top-line growth.

UK >1,000-qubit programme. Plans to invest up to $100m in the UK toward a >1,000-qubit system in 3–4 years anchor Rigetti as a credible counterparty to UK government quantum spending and the National Quantum Computing Centre.

India and sovereign demand. The $8.4m C-DAC purchase order for a 108-qubit system in the second half of 2026 is the largest single international commercial order to date and points to a broader sovereign-procurement cycle in friendly jurisdictions.

U.S. federal funding tailwind. The $2bn federal quantum investment programme announced in May 2026 (including IBM’s $1bn grant) is creating a sustained pipeline of government-funded research and procurement opportunities; Rigetti is well-positioned as a U.S.-domiciled superconducting specialist.

Modular architecture roadmap. The 108-qubit Cepheus is composed of twelve interconnected 9-qubit chiplets; the same chiplet-based approach is intended to extend toward 336-qubit and 1,000+ qubit systems in subsequent generations.

8. Peer Comparison

Rigetti is the smallest by current revenue among the quoted superconducting pure-plays, but enjoys the strongest balance-sheet flexibility relative to its market cap among true pure-plays. IBM dwarfs the entire category but is not a pure-play investment vehicle.

9. Insider Activity

Recent Form 4 activity is dominated by routine compensation grants rather than open-market discretionary trading.

The CEO’s 600,000-share option grant at $16.99 strike (issued March 2026) is the most significant recent insider transaction and is a multi-year retention award; the strike price is materially below the current share price, which is intentional under standard at-market option grant practice on the day of grant.

10. Key Risks

• Commercial-traction risk: Demonstrating useful quantum advantage on real-world enterprise workloads remains an open scientific question; without it, enterprise procurement cycles may stretch and revenue ramps may disappoint.
• Cash burn and dilution risk: FY2025 free cash flow was approximately −$77m; while the runway is multi-year, continued losses raise the possibility of further equity raises and dilution.
• Hyperscaler and incumbent competition: IBM, Google, Microsoft and AWS all have material quantum programmes — either in-house hardware or through orchestration platforms — that could marginalise Rigetti’s commercial pull.
• Technology execution risk: Scaling from 108 to >1,000 modular qubits in 3–4 years assumes that error-correction overhead and inter-chiplet coupling can be engineered to spec; any technical setback would damage the bull narrative.
• Volatile share price and sentiment risk: The 52-week range ($10.30 to $58.15) shows the share price has moved over 5x within a year; this volatility is a feature of speculative pure-play quantum stocks and exposes holders to large drawdowns.
• Regulatory and export-control risk: Quantum is increasingly treated as a strategic dual-use technology; new U.S. or allied export controls could constrain sales to certain foreign customers, particularly in Asia.
• Macro and capital-markets risk: Loss-making long-duration technology stocks are highly sensitive to interest-rate expectations and risk-on/risk-off market regimes; rate shocks can compress these multiples sharply.

11. Recent Developments

• 11 May 2026 — Q1 2026 results and Cepheus general availability. Rigetti reported Q1 2026 revenue of $4.4m (+193% YoY), GAAP net income of $33.1m (flattered by non-cash warrant remeasurement; non-GAAP net loss of $14.7m), operating loss of $26.0m, and ended the quarter with $569.0m of cash and zero debt. The company simultaneously announced general availability of its 108-qubit Cepheus-1-108Q system across Rigetti QCS, Amazon Braket, Microsoft Azure Quantum, and qBraid.
• May 2026 — UK >1,000-qubit programme. Rigetti announced plans to invest up to $100m in the UK toward a >1,000-qubit modular system within three to four years, anchoring its relationship with UK quantum customers and the National Quantum Computing Centre.
• May 2026 — India C-DAC order. Rigetti received an $8.4m purchase order to deliver a 108-qubit quantum computer to India’s Centre for Development of Advanced Computing, with deployment scheduled for the second half of 2026.
• 10 Apr 2026 — CEO option vesting begins. First monthly tranche of CEO Subodh Kulkarni’s 600,000-share option grant began vesting, with each tranche of one-thirty-sixth of the total vesting on the 10th day of each calendar month through 2029.
• 10 Mar 2026 — CEO 600,000-option grant. Board granted CEO Subodh Kulkarni 600,000 stock options at a $16.99 strike, expiring March 2036.
• March 2026 — FY2025 results. Full-year revenue of $7.1m (-34% YoY), GAAP net loss of $216.2m, accumulated deficit of $771m at year-end, FY2025 free cash flow of approximately −$77m.

12. Key Dates

• 9 Jun 2026 — Annual Meeting of Stockholders (virtual format), with CEO Subodh Kulkarni standing for re-election as director
• 11 Aug 2026 — Q2 2026 earnings release (expected, based on prior-period cadence)
• 31 Dec 2026 — Targeted deployment date for the 108-qubit C-DAC India system (second half of 2026)
• 10 Nov 2026 — Q3 2026 earnings release (anticipated, based on prior-period cadence)
• 11 Mar 2027 — Anticipated FY2026 full-year earnings release

Investors interested in tracking the technical setup intraday can view live charts on the ChartsView Live Charts page, monitor major macro releases on the Economic Calendar, and join the community discussion on the ChartsView Forum.

Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.